Page last updated: 2024-11-04

terazosin and Essential Hypertension

terazosin has been researched along with Essential Hypertension in 1 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Essential Hypertension: Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500

Research Excerpts

ExcerptRelevanceReference
"In an open multicenter prospective study, the effects of short-term (4 weeks, n = 101) and long-term (6 months, n = 38) terazosin treatment on blood pressure, serum lipids and safety in the patients with mild to moderate essential hypertension were observed."5.09Effect of terazosin on blood pressure and serum lipids. ( Cheng, L; Gong, P; Lu, Z; Tang, J; Zeng, F; Zhang, J, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, P1
Tang, J1
Cheng, L1
Lu, Z1
Zhang, J1
Zeng, F1

Trials

1 trial available for terazosin and Essential Hypertension

ArticleYear
Effect of terazosin on blood pressure and serum lipids.
    Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 1999, Volume: 19, Issue:4

    Topics: Antihypertensive Agents; Blood Pressure; Essential Hypertension; Humans; Hypercholesterolemia; Hyper

1999